Table 1 Demographic data for people with autism and healthy controlsa
Case | Dx | Sex | Age | PMI, hours | Ethnicity | Medication History | Cause of Death | Seizure | MR |
|---|---|---|---|---|---|---|---|---|---|
4670 | Control | M | 4 | 17 | Caucasian | None | Commotio Cordis | No | No |
1674 | Control | M | 8 | 36 | Caucasian | None | Drowning | No | No |
4787 | Control | M | 12 | 15 | African American | Montelukast, Albuteral, Prednisone, Loratadine | Asthma | No | No |
1823 | Control | M | 15 | 18 | Caucasian | None | MVA | No | No |
6396 | Control | M | 18 | 19.83 | Unknown | None | Unknown | No | No |
1846 | Control | F | 20 | 9 | Caucasian | None | MVA | No | No |
6316 | Control | F | 32 | 28.92 | Unknown | None | Unknown | No | No |
1169 | Control | M | 33 | 27 | African American | Metoclopramide, Loratadine | Dilated Cardiomyopathy (morbid obesity) | No | No |
1376 | Control | M | 37 | 12 | African American | None | ASCVD | No | No |
6420 | Control | M | 41 | 30.4 | Unknown | None | Heart Attack | No | No |
7002 | Autism | F | 5 | 32.73 | Asian | None | Drowning | No | No |
5569 | Autism | M | 5 | 39 | Caucasian | None | Drowning | No | No |
1174 | Autism | F | 7 | 14 | Caucasian | None | Seizure disorder | Yes | No |
5666 | Autism | M | 8 | 22.16 | Caucasian | None | Cancer | Yes | No |
4231 | Autism | M | 8 | 12 | African American | Olanzapine, Galantamine | Drowning | No | Yes |
4925 | Autism | M | 9 | 27 | Caucasian | Clonidine, Sodium valproate, Phenytoin, Lamotrigine, Methylphenidate, Carbamazepine | Seizure disorder | Yes | No |
4899 | Autism | M | 14 | 9 | Caucasian | None | Drowning | No | No |
6184 | Autism | F | 18 | 6.75 | Caucasian | None | Seizure disorder | Yes | No |
5144 | Autism | M | 20 | 23.66 | Caucasian | Erythromycin gel, Minocycline | MVA | No | Yes |
1638 | Autism | F | 20 | 50 | Caucasian | None | Seizure disorder | Yes | Yes |
6337 | Autism | M | 22 | 25 | Caucasian | Aripiprazole, Lamotrigine, Zonisamide | Aspiration | Yes | No |
6994 | Autism | M | 29 | 43.25 | Caucasian | Fexofenadine, Ziprasidone HCl, Carbamazepine | Seizure (suspected) | Yes | No |
6640 | Autism | F | 29 | 17.83 | Caucasian | Fluvoxamine | Seizure disorder | Yes | No |
6677 | Autism | M | 30 | 16.06 | Caucasian | None | Heart Failure (congestive) | No | No |
5173 | Autism | M | 30 | 20.33 | Caucasian | Cisapride, Clorazepate, Sodium valproate, Phenytoin, Folic Acid, Primidone, Phenobarbital, Omeprazole, Cisapride, Metoclopramide | Gastrointestinal bleeding | Yes | No |
5027 | Autism | M | 37 | 26 | African American | None | Obstruction of bowel due to adhesion | No | No |
6401 | Autism | M | 39 | 13.95 | Caucasian | None | Cardiac Tamonade | No | No |
5562 | Autism | M | 39 | 22.75 | Caucasian | None | Sudden unexpected death | Yes | No |
6469 | Autism | F | 49 | 16.33 | Caucasian | Wafarin, Venlafaxine, Erythromycin, Lansoprazole, Risperidone, Metformin, Gabapentin, Propranolol, Levothyroxine | Pulmonary Arrest | No | Yes |
4498 | Autism | M | 56 | 19.48 | Caucasian | Benztropine mesylate, Haloperidol, Lithium, Chlorpromazine, Alprazolam | Anoxic encephalopathy | Yes | No |
Children | Control | Autistic | Change | P value | Cohen's d | Â | Â | Â | Â |
Age ± SD (years) | 11.4 ± 5.55 | 9.25 ± 4.53 | ↓18.9% | ns | -- |  |  |  |  |
PMI ± SD (years) | 21.2 ± 8.47 | 18.6 ± 9.47 | ↓12.3% | ns | -- |  |  |  |  |
Gender | 5M | 5M:3F | -- | -- | -- | Â | Â | Â | Â |
Adults | Control | Autistic | Change | P value | Cohen's d | Â | Â | Â | Â |
Age ± SD (years) | 32.6 ± 7.89 | 33.3 ± 11.2 | ↑2.1% | ns | -- |  |  |  |  |
PMI ± SD (years) | 21.5 ± 10.1 | 24.6 ± 11.1 | ↑14.4% | ns | -- |  |  |  |  |
Gender | 3M:2F | 9M:3F | -- | -- | -- | Â | Â | Â | Â |